Julia completed a PhD Engineering in 2012, which focused on innovative financing solutions for global health. Stemming from her PhD research at Gates Cambridge, she originated, raised and deployed the world's first $108mm Global Health Investment Fund with Lion's Head Global Partners and the Bill and Melinda Gates Foundation. The purpose of the fund was to provide financing to advance the development of drugs, vaccines, diagnostics and other interventions against diseases that disproportionately burden low-income countries. Before coming to Cambridge, Julia qualified as a Chartered Accountant with KPMG's Canadian biotechnology practice and undertook projects for a variety of organisations including GAVI and WHO. During her time in Cambridge, Julia co-founded the African Innovation Prize, served on the University Council, and initiated and convened the Cambridge Global Health Commercialization and Funding Roundtable. Julia is currently based in London's White City biomedical campus as Co-Founder & CEO of Micrographia Bio, a deeptech bio company focused on applying machine learning to bioimaging to accelerate drug discovery.